Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | -232.1% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | 18.3 |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Apr-20 | n/a | (6.77) | (1.18)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-21 | n/a | (16.81) | (2.28)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-22 | n/a | (6.27) | (0.56)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-23 | 5.27 | (14.30) | (1.50)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-24 | n/a | (9.12) | (0.68)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Apr-25 | 5.67 | (13.15) | (1.21)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-26 | 1.25 | (12.66) | (1.06)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-27 | n/a | (17.95) | (1.43)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Director Dealing | 21-May-2025 | 07:00 | RNS |
Partnership with NHS Cancer Vaccine Launch Pad | 14-Apr-2025 | 07:00 | RNS |
Scancell to present at 2025 AACR Annual Meeting | 01-Apr-2025 | 07:00 | RNS |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
20-May-25 | Buy | Martin Diggle | 9.00p | 44,944 | £4,044.96 |
16-May-25 | Buy | Martin Diggle | 9.00p | 402,952 | £36,265.68 |
15-May-25 | Buy | Martin Diggle | 9.00p | 49,868 | £4,488.12 |
Currency | UK Pounds |
Share Price | 9.70p |
Change Today | -0.30p |
% Change | -3.00 % |
52 Week High | 19.50 |
52 Week Low | 7.50 |
Volume | 13,050 |
Shares Issued | 1,036.78m |
Market Cap | £100.57m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
09:02 | 8,900 @ 9.90p |
08:20 | 2,181 @ 9.90p |
08:02 | 1,969 @ 9.90p |
CFO | Sath Nirmalananthan |
CEO | Phil L'Huillier |
You are here: research